Artiva Biotherapeutics, Inc. (ARTV) Reports Q1 Loss of $0.83
Tweet
Share
E-mailGet Alerts ARTV Hot Sheet
Join SI Premium – FREE
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) reported Q1 EPS of ($0.83).
For earnings history and earnings-related data on Artiva Biotherapeutics, Inc. (ARTV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robinhood Ventures Fund II opens at $22.50, IPO at $25
- Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
- Ideal Power (IPWR) Tops Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
